Sept. 7, 2010
-- The report “Endometriosis:
Pipeline Assessment and Market Forecasts to 2017” available at www.reportbuyer.com/
go/GDA00789 is an essential source of information and analysis on the global endometriosis market. The report identifies the key trends shaping and driving the global endometriosis market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders.
The report estimates that the global endometriosis market was valued at $785m in 2009 and will grow at a CAGR of 4.3% to reach $1.1 billion by 2017. This modest growth forecast is primarily attributed to a weak pipeline landscape. The existing market is weak due to a lack of diagnostic techniques, disease awareness and the poor safety and efficacy profiles of the existing therapies. There is a high unmet need which is largely driven by the availability of drugs that are moderately successful in terms of safety and efficacy. The endometriosis market is primarily formed of generic and off-label drugs and has very few approved drugs which fall in the major therapeutic categories such as NSAIDs, oral contraceptives, GnRH agonists and progestins.
The report “Endometriosis:
Pipeline Assessment and Market Forecasts to 2017” is available from Report Buyer at:http://www.reportbuyer.com/pharma_healthcare/diseases/end...
Reportbuyer Product Code: GDA00789
Report Buyer http://www.reportbuyer.com/pharma_healthcare/diseases/ind...
is the online store for global business information. The website now lists more than 140,000 company overviews, market research reports, industry studies and business books from over 300 specialist publishers. Thousands of professionals from across the world make ReportBuyer.com their first choice in their search for quality business insight.
# # #
Report Buyer is a UK-based independent online store supplying business information on major industry sectors. These include the Automotive Industry, Banking & Finance, Energy & Utilities, Food & Drink, Telecoms and Pharma & Healthcare.